The in vitro micronucleus test on isolated human lymphocytes

Area of Science:

• Genotoxicity testing
• In vitro toxicology
• Mutagenesis research

Background:

• Assessing the genotoxic potential of chemical compounds is crucial for human health risk evaluation.
• The in vitro micronucleus test is a widely used method for detecting chromosomal damage.
• Metabolic activation systems are essential for evaluating promutagens that require biotransformation to exert their genotoxic effects.

Purpose of the Study:

• To evaluate the genotoxicity of five distinct chemical compounds using the in vitro micronucleus assay.
• To determine the necessity of metabolic activation for the genotoxic effects of these compounds.
• To validate the reliability of the in vitro micronucleus test with known positive controls.

Main Methods:

• Human lymphocytes were isolated and treated using the cytokinesis-block micronucleus test.
• Tests were conducted both with and without a rat liver metabolizing system (S9 mix).
• Positive controls (vincristine, cyclophosphamide, benzo[a]pyrene, dimethylbenz[a]anthracene) and test chemicals (safrole, azathioprine, procarbazine, diethylstilbestrol, o-toluidine) were used.

Main Results:

• Positive controls induced significant, dose-dependent increases in micronucleus frequency.
• o-Toluidine demonstrated marked direct genotoxicity; azathioprine showed genotoxicity with or without metabolic activation.
• Safrole and procarbazine were found to be non-genotoxic, while diethylstilbestrol yielded inconclusive results.

Conclusions:

• The in vitro micronucleus test, with and without metabolic activation, is a reliable system for assessing chemical genotoxicity.
• o-Toluidine and azathioprine are confirmed genotoxic agents.
• Safrole and procarbazine do not exhibit genotoxicity in this specific test system.